IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cutter Capital Management, LP

Q1 2024 Holdings

Filed 2024-05-15 | 26 holdings | $261.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2024-08-06) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bristol-Myers Squibb Co(BMY)COM110122108$24.2M446,9009.3%
Gilead Sciences Inc(GILD)COM375558103$19.4M265,4367.4%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$16.0M1,135,7106.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$15.7M16,3606.0%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$15.3M175,0005.8%
Ionis Pharmaceuticals Inc(IONS)COM462222100$12.5M289,3664.8%
Royalty Pharma PLC(RPRX)SHS CLASS AG7709Q104$12.5M411,5404.8%
Sarepta Therapeutics Inc(SRPT)COM803607100$12.2M94,3794.7%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$12.2M658,4094.7%
Biogen Inc(BIIB)COM09062X103$11.2M52,0004.3%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$10.7M2,105,4594.1%
Halozyme Therapeutics Inc(HALO)COM40637H109$10.4M255,0494.0%
Perrigo Co PLC(PRGO)SHSG97822103$10.4M322,1144.0%
Exelixis Inc(EXEL)COM30161Q104$9.5M398,7623.6%
Avadel Pharmaceuticals PLCSPONSORED ADRG29687103$9.2M541,9263.5%
ELI Lilly & Co(LLY)COM532457108$8.6M11,0403.3%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$8.4M288,5803.2%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$8.2M120,1853.1%
Arcellx Inc(ACLX)COMMON STOCK03940C100$7.4M107,0002.8%
Insmed Inc(INSM)COM PAR $.01457669307$6.2M227,3372.4%
Viridian Therapeutics Inc(VRDN)COM92790C104$4.9M278,6381.9%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$4.5M79,8301.7%
Kyverna Therapeutics Inc(KYTX)COM501976104$4.1M166,5141.6%
Pliant Therapeutics Inc(PLRX)COM729139105$2.9M194,1191.1%
Cabaletta BIO Inc(CABA)COM12674W109$2.7M157,9641.0%
Ironwood Pharmaceuticals Inc(IRWD)CallACOM CL A46333X108$2.2M250,0000.8%